These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 2499463)
21. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. Fujimoto T; Imaeda H; Takahashi K; Kasumi E; Bamba S; Fujiyama Y; Andoh A J Gastroenterol Hepatol; 2013 Apr; 28(4):613-9. PubMed ID: 23216550 [TBL] [Abstract][Full Text] [Related]
22. Induction of arthritis in rats by soluble peptidoglycan-polysaccharide complexes produced by human intestinal flora. Kool J; Ruseler-van Embden JG; van Lieshout LM; de Visser H; Gerrits-Boeye MY; van den Berg WB; Hazenberg MP Arthritis Rheum; 1991 Dec; 34(12):1611-6. PubMed ID: 1747146 [TBL] [Abstract][Full Text] [Related]
24. Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings. Hedin CR; McCarthy NE; Louis P; Farquharson FM; McCartney S; Taylor K; Prescott NJ; Murrells T; Stagg AJ; Whelan K; Lindsay JO Gut; 2014 Oct; 63(10):1578-86. PubMed ID: 24398881 [TBL] [Abstract][Full Text] [Related]
25. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. Scanlan PD; Shanahan F; O'Mahony C; Marchesi JR J Clin Microbiol; 2006 Nov; 44(11):3980-8. PubMed ID: 16988018 [TBL] [Abstract][Full Text] [Related]
26. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088 [TBL] [Abstract][Full Text] [Related]
27. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities. Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344 [TBL] [Abstract][Full Text] [Related]
28. Induction of chronic arthritis in rats by cell wall fragments of anaerobic coccoid rods isolated from the faecal flora of patients with Crohn's disease. Severijnen AJ; Hazenberg MP; van de Merwe JP Digestion; 1988; 39(2):118-25. PubMed ID: 3410168 [TBL] [Abstract][Full Text] [Related]
29. Detection of muramic acid in a carbohydrate fraction of human spleen. Hoijer MA; Melief MJ; van Helden-Meeuwsen CG; Eulderink F; Hazenberg MP Infect Immun; 1995 May; 63(5):1652-7. PubMed ID: 7729869 [TBL] [Abstract][Full Text] [Related]
30. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Benjamin JL; Hedin CR; Koutsoumpas A; Ng SC; McCarthy NE; Hart AL; Kamm MA; Sanderson JD; Knight SC; Forbes A; Stagg AJ; Whelan K; Lindsay JO Gut; 2011 Jul; 60(7):923-9. PubMed ID: 21262918 [TBL] [Abstract][Full Text] [Related]
31. Culturing and extraction of Coprococcus comes, absorption of serumagglutinins by soluble fractions and relation between agglutinins and antibodies in sera of patients with Crohn's disease. Hazenberg MP; Pennock-Schröder AM; van de Merwe JP Med Microbiol Immunol; 1986; 175(5):299-306. PubMed ID: 3762491 [TBL] [Abstract][Full Text] [Related]
32. Fecal bacteria from Crohn's disease patients more potently activated NOD-like receptors and Toll-like receptors in macrophages, in an IL-4-repressible fashion. Gu J; Liu G; Xing J; Song H; Wang Z Microb Pathog; 2018 Aug; 121():40-44. PubMed ID: 29752990 [TBL] [Abstract][Full Text] [Related]
33. Agglutination of Eubacterium and Peptostreptococcus species as a diagnostic test for Crohn's disease. van de Merwe JP Hepatogastroenterology; 1981 Jun; 28(3):155-6. PubMed ID: 7250896 [TBL] [Abstract][Full Text] [Related]
34. Proceedings: The faecal flora of patients with Crohn's disease. Wensinck F Antonie Van Leeuwenhoek; 1975; 41(2):214-5. PubMed ID: 1080400 [No Abstract] [Full Text] [Related]
35. Polysaccharide covalently linked to the peptidoglycan of the cyanobacterium Synechocystis sp. strain PCC6714. Jürgens UJ; Weckesser J J Bacteriol; 1986 Nov; 168(2):568-73. PubMed ID: 3096958 [TBL] [Abstract][Full Text] [Related]
36. A microbial signature for Crohn's disease. Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361 [TBL] [Abstract][Full Text] [Related]
37. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. Giaffer MH; Holdsworth CD; Duerden BI J Med Microbiol; 1991 Oct; 35(4):238-43. PubMed ID: 1941994 [TBL] [Abstract][Full Text] [Related]
38. Microbial Population Differentials between Mucosal and Submucosal Intestinal Tissues in Advanced Crohn's Disease of the Ileum. Chiodini RJ; Dowd SE; Chamberlin WM; Galandiuk S; Davis B; Glassing A PLoS One; 2015; 10(7):e0134382. PubMed ID: 26222621 [TBL] [Abstract][Full Text] [Related]
39. Structural elucidation of a capsular polysaccharide from a clinical isolate of Bacteroides vulgatus from a patient with Crohn's disease. Hashimoto M; Kirikae F; Dohi T; Kusumoto S; Suda Y; Kirikae T Eur J Biochem; 2001 Jun; 268(11):3139-44. PubMed ID: 11389714 [TBL] [Abstract][Full Text] [Related]
40. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease. Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]